You are here

CERID Bibliography

Export 43 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Toll-Like Receptors  [Clear All Filters]
Journal Article
Bergman MA, Cummings LA, Barrett SLRassouli, Smith KD, J Lara C, Aderem A, Cookson BT. CD4+ T cells and toll-like receptors recognize Salmonella antigens expressed in bacterial surface organelles. Infect Immun. 2005 ;73(3):1350-6.
Hawn TR, Verbon A, Lettinga KD, Zhao LPing, Li SSue, Laws RJ, Skerrett SJ, Beutler B, Schroeder L, Nachman A, et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J Exp Med. 2003 ;198(10):1563-72.
Bochud P-Y, Hawn TR, Aderem A. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immunol. 2003 ;170(7):3451-4.
Andersen-Nissen E, Hawn TR, Smith KD, Nachman A, Lampano AE, Uematsu S, Akira S, Aderem A. Cutting edge: Tlr5-/- mice are more susceptible to Escherichia coli urinary tract infection. J Immunol. 2007 ;178(8):4717-20.
D O'Mahony S, Pham U, Iyer R, Hawn TR, W Liles C. Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages. Int J Med Sci. 2008 ;5(1):1-8.
Li K, Chen Z, Kato N, Gale M, Lemon SM. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem. 2005 ;280(17):16739-47.
Finney CAM, Lu Z, Hawkes M, Yeh W-C, W Liles C, Kain KC. Divergent roles of IRAK4-mediated innate immune responses in two experimental models of severe malaria. Am J Trop Med Hyg. 2010 ;83(1):69-74.
Zhu X, Chang MSook, Hsueh RC, Taussig R, Smith KD, Simon MI, Choi S. Dual ligand stimulation of RAW 264.7 cells uncovers feedback mechanisms that regulate TLR-mediated gene expression. J Immunol. 2006 ;177(7):4299-310.
Andersen-Nissen E, Smith KD, Strobe KL, Barrett SLRassouli, Cookson BT, Logan SM, Aderem A. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci U S A. 2005 ;102(26):9247-52.
Roach JC, Glusman G, Rowen L, Kaur A, Purcell MK, Smith KD, Hood LE, Aderem A. The evolution of vertebrate Toll-like receptors. Proc Natl Acad Sci U S A. 2005 ;102(27):9577-82.
Ogushi K-ichi, Wada A, Niidome T, Okuda T, Llanes R, Nakayama M, Nishi Y, Kurazono H, Smith KD, Aderem A, et al. Gangliosides act as co-receptors for Salmonella enteritidis FliC and promote FliC induction of human beta-defensin-2 expression in Caco-2 cells. J Biol Chem. 2004 ;279(13):12213-9.
Kajikawa O, Frevert CW, Lin S-M, Goodman RB, Mongovin SM, Wong V, Ballman K, Daubeuf B, Elson G, Martin TR. Gene expression of Toll-like receptor-2, Toll-like receptor-4, and MD2 is differentially regulated in rabbits with Escherichia coli pneumonia. Gene. 2005 ;344:193-202.
Baker AR, Qiu F, Randhawa AKaur, Horne DJ, Adams MD, Shey M, Barnholtz-Sloan J, Mayanja-Kizza H, Kaplan G, Hanekom WA, et al. Genetic variation in TLR genes in Ugandan and South African populations and comparison with HapMap data. PLoS One. 2012 ;7(10):e47597.
Dunstan SJ, Hawn TR, Hue NThi, Parry CP, Ho VAn, Vinh H, Diep TSong, House D, Wain J, Aderem A, et al. Host susceptibility and clinical outcomes in toll-like receptor 5-deficient patients with typhoid fever in Vietnam. J Infect Dis. 2005 ;191(7):1068-71.
Doehle BP, Hladik F, McNevin JP, McElrath JM, Gale M. Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells. J Virol. 2009 ;83(20):10395-405.
Hawn TR, Ozinsky A, Williams LM, Rodrigues S, Clark A, Pham U, Hill HR, Ochs H, Aderem A, W Liles C. Hyper-IgE syndrome is not associated with defects in several candidate toll-like receptor pathway genes. Hum Immunol. 2005 ;66(7):842-7.
Li K, Foy E, Ferreon JC, Nakamura M, Ferreon ACM, Ikeda M, Ray SC, Gale M, Lemon SM. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A. 2005 ;102(8):2992-7.
Erdman LK, Finney CAM, W Liles C, Kain KC. Inflammatory pathways in malaria infection: TLRs share the stage with other components of innate immunity. Mol Biochem Parasitol. 2008 ;162(2):105-11.
Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 2001 ;410(6832):1099-103.
Martin TR, Frevert CW. Innate immunity in the lungs. Proc Am Thorac Soc. 2005 ;2(5):403-11.
Lazear HM, Lancaster A, Wilkins C, Suthar MS, Huang A, Vick SC, Clepper L, Thackray L, Brassil MM, Virgin HW, et al. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog. 2013 ;9(1):e1003118.
Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004 ;432(7019):917-21.
Smith KD. Lupus nephritis: toll the trigger!. J Am Soc Nephrol. 2006 ;17(12):3273-5.
Berrington WR, Hawn TR. Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?. Immunol Rev. 2007 ;219:167-86.
Giordano D, Li C, Suthar MS, Draves KE, Ma DY, Gale M, Clark EA. Nitric oxide controls an inflammatory-like Ly6C(hi)PDCA1+ DC subset that regulates Th1 immune responses. J Leukoc Biol. 2011 ;89(3):443-55.

Pages